bf/NASDAQ:SANA_icon.jpeg

COM:SANA

Sana Biotechnology, Inc.

  • Stock

Last Close

2.53

21/11 21:00

Market Cap

1.15B

Beta: -

Volume Today

200

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
144.50K
-
1.13M
679.58%
2.24M
98.49%
2.54M
13.51%
3.48M
37.21%
average receivables
book value per share
-1.09
-
-2.40
119.56%
4.38
282.20%
2.65
39.43%
1.48
44.25%
capex per share
-0.20
-
-0.14
32.25%
-0.18
31.77%
-0.11
38.22%
-0.10
7.10%
capex to depreciation
-14.34
-
-4.03
71.88%
-2.70
33.09%
-1.34
50.47%
-0.65
51.42%
capex to operating cash flow
0.31
-
0.17
43.50%
0.12
31.25%
0.07
39.49%
0.08
9.76%
capex to revenue
cash per share
1.07
-
3.80
255.77%
3.31
12.78%
2.25
32.01%
1.07
52.27%
days of inventory on hand
days payables outstanding
48.58
-
days sales outstanding
debt to assets
0.12
-
0.10
15.09%
0.10
0.24%
0.13
33.95%
0.18
39.95%
debt to equity
-0.34
-
-0.17
49.52%
0.15
189.20%
0.22
42.36%
0.36
67.00%
dividend yield
earnings yield
-0.03
-
-0.05
58.31%
-0.13
195.03%
-0.36
168.03%
-0.36
0.34%
enterprise value
-30.63M
-
4.54B
14,923.83%
5.81B
28.03%
2.43B
58.13%
675.45M
72.25%
760.47M
12.59%
enterprise value over ebitda
-32.59
-
-20.32
37.66%
-6.82
66.43%
-2.48
63.67%
-2.58
4.05%
ev to operating cash flow
-53.10
-
-42.13
20.66%
-9.70
76.99%
-2.33
75.98%
-3.00
28.78%
ev to sales
free cash flow per share
-0.86
-
-0.92
7.68%
-1.69
82.82%
-1.65
2.19%
-1.41
14.80%
free cash flow yield
-0.02
-
-0.03
7.68%
-0.11
314.54%
-0.42
283.30%
-0.34
17.52%
graham net net
-3.22
-
-2.77
13.86%
0.90
132.53%
0.53
40.80%
-0.35
166.21%
graham number
4.97
-
9.27
86.44%
14.27
53.97%
9.19
35.64%
6.96
24.25%
income quality
0.65
-
0.48
26.03%
0.71
45.85%
1.08
52.60%
0.90
16.83%
intangibles to total assets
0
-
0.48
Infinity%
0.27
43.08%
0.18
35.34%
0.24
37.28%
0.35
45.54%
interest coverage
17.44
-
interest debt per share
0.37
-
0.41
10.84%
0.67
62.52%
0.49
26.22%
0.54
8.80%
inventory turnover
invested capital
-0.34
-
-0.17
49.52%
0.15
189.20%
0.22
42.36%
0.36
67.00%
market cap
4.57B
-
6.15B
34.58%
2.58B
58.13%
743.96M
71.12%
793.73M
6.69%
net current asset value
-14.93M
-
-413.98M
2,673.72%
-767.01M
85.28%
157.20M
120.49%
121.03M
23.01%
-64.28M
153.11%
net debt to ebitda
0.23
-
1.19
420.34%
0.40
66.50%
0.25
36.86%
0.11
55.15%
net income per share
-1.00
-
-1.59
58.31%
-2.07
30.12%
-1.41
31.61%
-1.46
2.94%
operating cash flow per share
-0.66
-
-0.79
19.91%
-1.51
91.66%
-1.54
2.09%
-1.30
15.36%
payables turnover
7.51
-
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.61
-
-0.53
13.29%
-0.37
29.51%
-0.43
15.50%
-0.78
81.23%
revenue per share
roe
0.92
-
0.66
27.89%
-0.47
171.42%
-0.53
12.92%
-0.99
84.67%
roic
2.89
-
1.01
65.17%
-0.36
136.04%
-0.38
3.65%
-0.68
79.39%
sales general and administrative to revenue
shareholders equity per share
-1.09
-
-2.40
119.56%
4.38
282.20%
2.65
39.43%
1.48
44.25%
stock based compensation to revenue
tangible asset value
-13.19M
-
-342.36M
2,496.03%
-621.01M
81.39%
528.68M
185.13%
299.49M
43.35%
87.68M
70.72%
tangible book value per share
-2.63
-
-3.54
34.78%
3.18
189.68%
1.59
49.94%
0.45
71.66%
working capital
30.81M
-
124.43M
303.86%
353.02M
183.70%
458.87M
29.98%
332.93M
27.44%
149.03M
55.24%

All numbers in (except ratios and percentages)